You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for Patent: 11,027,072


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,027,072 protect, and when does it expire?

Patent 11,027,072 protects ZIMHI and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 11,027,072
Title:Emergency devices
Abstract: Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose. Also provided herein are compositions and methods of treating opioid overdose using high dose naloxone.
Inventor(s): Flather; Mark J. (San Diego, CA), Daniels; Karen K. (San Diego, CA), Moll; Thomas (San Diego, CA), Moss; Ronald B. (San Diego, CA), Carlo; Dennis J. (San Diego, CA)
Assignee: Adamis Pharmaceuticals Corporation (San Diego, CA)
Application Number:16/592,319
Patent Claim Types:
see list of patent claims
Composition; Device;

Drugs Protected by US Patent 11,027,072

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Zmi Pharma ZIMHI naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 212854-001 Oct 15, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,027,072

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019272966 ⤷  Sign Up
Canada 3100913 ⤷  Sign Up
China 112469458 ⤷  Sign Up
European Patent Office 3801699 ⤷  Sign Up
Israel 278999 ⤷  Sign Up
Japan 2021524328 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.